Your browser doesn't support javascript.
loading
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
Srour, S A; Singh, H; McCarty, J; de Groot, E; Huls, H; Rondon, G; Qazilbash, M; Ciurea, S; Bardelli, G; Buck, J; Alousi, A; Nieto, Y; Rezvani, K; Marin, D; Popat, U; Hosing, C; Shpall, E J; Wierda, W G; Kantarjian, H; Champlin, R E; Cooper, L J; Kebriaei, P.
Afiliação
  • Srour SA; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Singh H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • McCarty J; Department of Stem Cell Transplantation and Cellular Therapy and.
  • de Groot E; Ziopharm Oncology, Boston, MA; and.
  • Huls H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Qazilbash M; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Ciurea S; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Bardelli G; Ziopharm Oncology, Boston, MA; and.
  • Buck J; Ziopharm Oncology, Boston, MA; and.
  • Alousi A; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Marin D; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Hosing C; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy and.
  • Cooper LJ; Ziopharm Oncology, Boston, MA; and.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy and.
Blood ; 135(11): 862-865, 2020 03 12.
Article em En | MEDLINE | ID: mdl-31961918

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Linfoma de Células B / Antígenos CD19 / Antígenos de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Linfoma de Células B / Antígenos CD19 / Antígenos de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article